Boswellia Serrata Supplementation Joint Function Meta-Analysis Evidence Table

Structured evidence table for Boswellia Serrata Supplementation Joint Function Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Boswellia Serrata Supplementation Joint Function Meta-AnalysisThe trial results revealed that BSE treatment significantly improved the physical function of the patients by reducing pain and stiffness compared with placebo.2Majeed M (2019)A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisRadiographic assessments showed improved knee joint gap and reduced osteophytes (spur) confirming the efficacy of BSE treatment.2Majeed M (2019)A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisBSE also significantly reduced the serum levels of high-sensitive C-reactive protein, a potential inflammatory marker associated with OA of the knee.2Majeed M (2019)A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisA double-blind, placebo-controlled human trial was conducted to evaluate the safety and efficacy of a standardized oral supplementation of Boswellin®, a novel extract of Boswellia serrata extract (BSE) containing 3-acetyl-11-keto-β-boswellic acid (AKBBA) with β-boswellic acid (BBA).2Majeed M (2019)A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisEarlier, NXT15906F6 supplementation demonstrated reduced knee joint pain and improved musculoskeletal functions in healthy and knee osteoarthritis (KOA) subjects.4Prasad N (2023)Efficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisResults NXT15906F6 significantly ( P Conclusion The anti-inflammatory botanical composition NXT15906F6 supplementation mitigated joint pain and improved musculoskeletal functions and joint motility in KOA subjects.4Prasad N (2023)Efficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.
Boswellia Serrata Supplementation Joint Function Meta-AnalysisBackground NXT15906F6 (TamaFlex™) is a proprietary blend containing standardized Tamarindus indica seeds and Curcuma longa rhizome extracts.4Prasad N (2023)Efficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimThe trial results revealed that BSE treatment significantly improved the physical function of the patients by reducing pain and stiffness compared with placebo.
evidence level2
citationMajeed M (2019)
sourceA pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimRadiographic assessments showed improved knee joint gap and reduced osteophytes (spur) confirming the efficacy of BSE treatment.
evidence level2
citationMajeed M (2019)
sourceA pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimBSE also significantly reduced the serum levels of high-sensitive C-reactive protein, a potential inflammatory marker associated with OA of the knee.
evidence level2
citationMajeed M (2019)
sourceA pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimA double-blind, placebo-controlled human trial was conducted to evaluate the safety and efficacy of a standardized oral supplementation of Boswellin®, a novel extract of Boswellia serrata extract (BSE) containing 3-acetyl-11-keto-β-boswellic acid (AKBBA) with β-boswellic acid (BBA).
evidence level2
citationMajeed M (2019)
sourceA pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimEarlier, NXT15906F6 supplementation demonstrated reduced knee joint pain and improved musculoskeletal functions in healthy and knee osteoarthritis (KOA) subjects.
evidence level4
citationPrasad N (2023)
sourceEfficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimResults NXT15906F6 significantly ( P Conclusion The anti-inflammatory botanical composition NXT15906F6 supplementation mitigated joint pain and improved musculoskeletal functions and joint motility in KOA subjects.
evidence level4
citationPrasad N (2023)
sourceEfficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.
topicBoswellia Serrata Supplementation Joint Function Meta-Analysis
claimBackground NXT15906F6 (TamaFlex™) is a proprietary blend containing standardized Tamarindus indica seeds and Curcuma longa rhizome extracts.
evidence level4
citationPrasad N (2023)
sourceEfficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.

Source documents

  1. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
  2. Efficacy of a proprietary combination of <i>Tamarindus indica</i> seeds and <i>Curcuma longa</i> rhizome extracts in osteoarthritis: a clinical investigation.